Inovio Biomedical Corporation to Present at Investor Conferences

May 5, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

BLUE BELL, Pa.--(BUSINESS WIRE)--Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today that senior executives of the company will present at the following investor conferences:

Twitter
LinkedIn
Facebook
Email
Print

Events